Chen Ding

Research Interests: The laboratory focuses on proteome-centered clinical multi-omics research, establishing the one-stop proteomics technology and data platform Firmiana. Independently developed key technologies including catTFRE, modi-TFRE, and ATAC-MS for parsing transcription factor activity, DNA modification binding preferences, and chromatin accessibility domain protein machinery. Based on this foundation, completed multi-omics mapping of various tumors (brain, digestive tract, urinary system, squamous cell carcinoma, sarcoma, melanoma, breast cancer, lung cancer, etc.), systematically elucidating trans-omics molecular regulatory networks and tumor-specific driver pathways.